Janux Therapeutics, Inc. (JANX)

13.06 -0.36 (-2.68%) USD  |  NASDAQ  |  Feb 20, 14:54
More

Janux Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for JANX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Bristol Myers Squibb Co. Upgrade
Eli Lilly & Co. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
MannKind Corp. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade